Meitheal Pharmaceuticals, Inc.

Meitheal Pharmaceuticals, Inc. company information, Employees & Contact Information

Founded in 2017, Meitheal Pharmaceuticals is a privately owned pharmaceutical company focusing on generic injectable products. Headquartered near Chicago, Illinois, Meitheal has an established management team and an aggressive growth strategy. Through global partnerships, our goal is to bring supply to US healthcare providers that demand a reliable, high quality, yet affordable supply of injectables.

Company Details

Employees
126
Founded
-
Address
8700 W Bryn Mawr Ave,
Phone
224-443-4617
Email
in****@****rma.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Chicago, Illinois
Looking for a particular Meitheal Pharmaceuticals, Inc. employee's phone or email?

Meitheal Pharmaceuticals, Inc. Questions

News

Meitheal Pharmaceuticals Secures Exclusive Commercial Licensing Agreement for Three Biosimilars in the U.S. - Yahoo Finance

Meitheal Pharmaceuticals Secures Exclusive Commercial Licensing Agreement for Three Biosimilars in the U.S. Yahoo Finance

Meitheal Pharmaceuticals to Present New Data in Infectious Disease Portfolio at IDWeek 2025 - FinancialContent

Meitheal Pharmaceuticals to Present New Data in Infectious Disease Portfolio at IDWeek 2025 FinancialContent

Meitheal Pharmaceuticals Announces Launch of Generic Paclitaxel Formulation in the United States Through Exclusive Commercial Licensing Agreement - Yahoo Finance

Meitheal Pharmaceuticals Announces Launch of Generic Paclitaxel Formulation in the United States Through Exclusive Commercial Licensing Agreement Yahoo Finance

Meitheal Pharmaceuticals Announces Approval and Launch of Liraglutide Injection in the United States - FinancialContent

Meitheal Pharmaceuticals Announces Approval and Launch of Liraglutide Injection in the United States FinancialContent

Meitheal Pharmaceuticals Grows Specialty Biopharmaceuticals Portfolio with Exclusive Commercial Licensing Agreement for XENLETA® (lefamulin acetate) - FinancialContent

Meitheal Pharmaceuticals Grows Specialty Biopharmaceuticals Portfolio with Exclusive Commercial Licensing Agreement for XENLETA® (lefamulin acetate) FinancialContent

Meitheal is Ranked #4 on Crain’s 2023 Fast 50 in Chicago - Business Wire

Meitheal is Ranked #4 on Crain’s 2023 Fast 50 in Chicago Business Wire

Top Meitheal Pharmaceuticals, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant